Related Experiment Video
Updated: Jul 30, 2025
10:57
Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
Published on: August 14, 2018
10.8K
FRET probe for detecting two mutations in one EGFR mRNA
Myat Thu1, Kouta Yanai1, Hajime Shigeto2
1Department of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Japan. ohtsuk@okayama-u.ac.jp.
The Analyst
|May 16, 2023
Summary
This study introduces a novel probe set for simultaneously detecting two mutations in epidermal growth factor receptor (EGFR) mRNA using fluorescence resonance energy transfer (FRET). This method enables visualization of mutant RNA in living cells.
Area of Science:
- Molecular Biology
- Biotechnology
- Cancer Research
Background:
- Accurate RNA visualization and tracking are critical in molecular biology and disease research.
- Detecting multiple mutations in specific RNA molecules, such as epidermal growth factor receptor (EGFR) mRNA, is crucial for understanding disease progression and treatment resistance.
Purpose of the Study:
- To develop and validate a novel probe set for simultaneous detection of two distinct mutations within a single RNA molecule.
- To utilize fluorescence resonance energy transfer (FRET) for detecting cancer-related (exon19del) and drug-resistance (T790M) mutations in EGFR mRNA.
Main Methods:
- Design of a dual-probe system (DAt-probe and T-probe) incorporating specific fluorophores and quenchers.
- Utilizing FRET to signal the presence of both exon19del and T790M mutations in EGFR mRNA.
- Validation using gel electrophoresis, FRET ratio measurements with wild-type and mutant RNAs, and visualization in living cells.
Main Results:
- The DAt-probe and T-probe efficiently bound to mutant EGFR mRNA, as confirmed by gel electrophoresis.
- A significant difference in FRET ratios was observed between wild-type and double-mutant RNAs.
- The FRET probe successfully visualized mutant EGFR mRNA within living cells.
Conclusions:
- The developed FRET-based probe set offers a sensitive and specific method for simultaneously detecting two mutations in EGFR mRNA.
- This technology has potential applications in cancer diagnostics and monitoring drug resistance.
- The probe set enables real-time visualization of mutant RNA, advancing RNA tracking technologies.
